Follow
Dr. Juan Pablo Maianti
Dr. Juan Pablo Maianti
Verified email at fas.harvard.edu
Title
Cited by
Cited by
Year
Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction
LW Koblan, JL Doman, C Wilson, JM Levy, T Tay, GA Newby, JP Maianti, ...
Nature biotechnology 36 (9), 843-846, 2018
7662018
Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones
JP Maianti, A McFedries, ZH Foda, RE Kleiner, XQ Du, MA Leissring, ...
Nature 511 (7507), 94-98, 2014
2682014
Second-generation DNA-templated macrocycle libraries for the discovery of bioactive small molecules
DL Usanov, AI Chan, JP Maianti, DR Liu
Nature chemistry 10 (7), 704-714, 2018
1562018
Editing of CCR5 receptor gene to protect against HIV infection
JP Maianti, DR Liu
US Patent 10,745,677, 2020
432020
Substrate-selective inhibitors that reprogram the activity of insulin-degrading enzyme
JP Maianti, GA Tan, A Vetere, AJ Welsh, BK Wagner, MA Seeliger, DR Liu
Nature chemical biology 15 (6), 565-574, 2019
412019
Gene editing of pcsk9
JP Maianti, DR Liu
US Patent App. 15/852,526, 2018
412018
Incorporation of unnatural amino acids into proteins using base editing
JP Maianti, DR Liu, LW Koblan
US Patent 11,542,509, 2023
292023
Macrocyclic insulin-degrading enzyme (IDE) inhibitors and uses thereof
DR Liu, JP Maianti, A Saghatelian, RE Kleiner
US Patent 9,243,038, 2016
282016
Hybrid Aminoglycoside Antibiotics via Tsuji Palladium-Catalyzed Allylic Deoxygenation
S Hanessian, JP Maianti, RD Matias, LA Feeney, ES Armstrong
Organic letters 13 (24), 6476-6479, 2011
282011
Synthesis and Comparative Antibacterial Activity of Verdamicin C2 and C2a. A New Oxidation of Primary Allylic Azides in Dihydro[2H]pyrans
S Hanessian, J Szychowski, JP Maianti
Organic letters 11 (2), 429-432, 2009
282009
Editing of CCR2 receptor gene to protect against HIV infection
JP Maianti, DR Liu
US Patent 11,820,969, 2023
232023
Synthesis, broad spectrum antibacterial activity, and X-ray co-crystal structure of the decoding bacterial ribosomal A-site with 4′-deoxy-4′-fluoro neomycin analogs
S Hanessian, OM Saavedra, MA Vilchis-Reyes, JP Maianti, H Kanazawa, ...
Chemical Science 5 (12), 4621-4632, 2014
232014
Toxicity modulation, resistance enzyme evasion, and A-site X-ray structure of broad-spectrum antibacterial neomycin analogs
JP Maianti, H Kanazawa, P Dozzo, RD Matias, LA Feeney, ES Armstrong, ...
ACS chemical biology 9 (9), 2067-2073, 2014
222014
Toward Overcoming Staphylococcus aureus Aminoglycoside Resistance Mechanisms with a Functionally Designed Neomycin Analogue
S Hanessian, A Giguere, J Grzyb, JP Maianti, OM Saavedra, JB Aggen, ...
ACS Medicinal Chemistry Letters 2 (12), 924-928, 2011
222011
Antibacterial aminoglycoside analogs
JB Aggen, AA Goldblum, DJ Hildebrandt, TR Kane, P Dozzo, MJ Gliedt, ...
US Patent 8,399,419, 2013
212013
Suppression of pain by gene editing
JP Maianti, DR Liu
US Patent 11,898,179, 2024
192024
Cancer vaccine
JP Maianti, DR Liu
US Patent App. 16/492,534, 2021
182021
Macrocyclic insulin-degrading enzyme (IDE) inhibitors and uses thereof
DR Liu, JP Maianti, A Saghatelian, RE Kleiner
US Patent 9,610,322, 2017
182017
The fungicide Mancozeb induces metacaspase-dependent apoptotic cell death in Saccharomyces cerevisiae BY4741
FJ Scariot, LM Jahn, JP Maianti, APL Delamare, S Echeverrigaray
Apoptosis 21, 866-872, 2016
182016
Structural hybridization of three aminoglycoside antibiotics yields a potent broad-spectrum bactericide that eludes bacterial resistance enzymes
JP Maianti, S Hanessian
MedChemComm 7 (1), 170-176, 2016
172016
The system can't perform the operation now. Try again later.
Articles 1–20